Senseonics Holdings, Inc. (SENS): Price and Financial Metrics

Senseonics Holdings, Inc. (SENS): $3.87

0.10 (+2.65%)

POWR Rating

Component Grades














  • Growth is the dimension where SENS ranks best; there it ranks ahead of 87.22% of US stocks.
  • The strongest trend for SENS is in Momentum, which has been heading down over the past 37 weeks.
  • SENS's current lowest rank is in the Stability metric (where it is better than 0.84% of US stocks).

SENS Stock Summary

  • SENS's price/sales ratio is 157.68; that's higher than the P/S ratio of 97.51% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Senseonics Holdings Inc is reporting a growth rate of 501.8%; that's higher than 95.49% of US stocks.
  • The volatility of Senseonics Holdings Inc's share price is greater than that of 95.25% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Senseonics Holdings Inc, a group of peers worth examining would be NSTG, VBIV, AFIB, QTWO, and LPSN.
  • Visit SENS's SEC page to see the company's official filings. To visit the company's web site, go to

SENS Valuation Summary

  • In comparison to the median Healthcare stock, SENS's price/earnings ratio is 108.77% lower, now standing at -3.2.
  • Over the past 69 months, SENS's price/sales ratio has gone down 6313.4.
  • SENS's price/sales ratio has moved down 6313.4 over the prior 69 months.

Below are key valuation metrics over time for SENS.

Stock Date P/S P/B P/E EV/EBIT
SENS 2021-08-31 165.5 -5.7 -3.2 -3.3
SENS 2021-08-30 157.3 -5.4 -3.1 -3.1
SENS 2021-08-27 167.2 -5.8 -3.2 -3.3
SENS 2021-08-26 160.2 -5.5 -3.1 -3.2
SENS 2021-08-25 153.5 -5.3 -3.0 -3.1
SENS 2021-08-24 151.1 -5.2 -2.9 -3.0

SENS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SENS has a Quality Grade of D, ranking ahead of 13.74% of graded US stocks.
  • SENS's asset turnover comes in at 0.084 -- ranking 70th of 75 Measuring and Control Equipment stocks.
  • MTD, ELSE, and PKI are the stocks whose asset turnover ratios are most correlated with SENS.

The table below shows SENS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.084 0.401 -5.465
2021-03-31 0.098 0.360 -5.709
2020-12-31 0.127 -3.509 -2.449
2020-09-30 0.158 -2.814 -1.660
2020-06-30 0.144 -2.385 -1.365
2020-03-31 0.165 -1.997 -1.885

SENS Stock Price Chart Interactive Chart >

Price chart for SENS

SENS Price/Volume Stats

Current price $3.87 52-week high $5.56
Prev. close $3.77 52-week low $0.35
Day low $3.77 Volume 6,831,300
Day high $3.89 Avg. volume 34,078,645
50-day MA $3.35 Dividend yield N/A
200-day MA $2.61 Market Cap 1.72B

Senseonics Holdings, Inc. (SENS) Company Bio

Senseonics Holdings, Inc. focuses on the design, development, and commercialization of glucose monitoring systems for people with diabetes. The company was founded in 1996 and is based in Germantown, Maryland.

SENS Latest News Stream

Event/Time News Detail
Loading, please wait...

SENS Latest Social Stream

Loading social stream, please wait...

View Full SENS Social Stream

Latest SENS News From Around the Web

Below are the latest news stories about Senseonics Holdings Inc that investors may wish to consider to help them evaluate SENS as an investment opportunity.

Use Recent Rally to Take Profits in Senseonics

Sensesonics has quite a ways to go before reaching commercial success.

Ian Bezek on InvestorPlace | September 13, 2021

Senseonics Stock Looks Like It Is Going to Stay Rangebound for a While

It’s a risk to have one company account for much of your revenue.

Will Ashworth on InvestorPlace | September 13, 2021

Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio

GERMANTOWN, Md., September 13, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, and Ascensia Diabetes Care, the makers of the CONTOUR® family of diabetes blood glucose monitoring devices and commercialization partner for Senseonics, have announced that the University Hospitals Accountable Care Organiz

Yahoo | September 13, 2021

7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

This sector is always a risky area to gamble in.

Josh Enomoto on InvestorPlace | September 10, 2021

Senseonics to Participate in the H.C. Wainwright Global Investment Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantab

Business Wire | September 9, 2021

Read More 'SENS' Stories Here

SENS Price Returns

1-mo 27.30%
3-mo 11.85%
6-mo 17.99%
1-year 865.81%
3-year -6.52%
5-year -2.76%
YTD 343.91%
2020 -4.83%
2019 -64.63%
2018 -2.63%
2017 -0.37%
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7872 seconds.